4-Phenylbutyric acid improves free fatty acid-induced hepatic insulin resistance in vivo

Plasma free fatty acids (FFAs) are elevated in obesity and can induce insulin resistance via endoplasmic reticulum (ER) stress. However, it is unknown whether hepatic insulin resistance caused by the elevation of plasma FFAs is alleviated by chemical chaperones. Rats received one of the following i.v. treatments for 48 h: saline, intralipid plus heparin (IH), IH plus the chemical chaperone 4-phenylbutyric acid (PBA), or PBA alone and a hyperinsulinemic-euglycemic clamp was performed during the last 2 h. PBA co-infusion normalized IH-induced peripheral insulin resistance, similar to our previous findings with an antioxidant and an IκBα kinase β (IKKβ) inhibitor. Different from our previous results with the antioxidant and IKKβ inhibitor, PBA also improved IH-induced hepatic insulin resistance in parallel with activation of Akt. Unexpectedly, IH did not induce markers of ER stress in the liver, but PBA prevented IH-induced elevation of phosphorylated eukaryotic initiation factor-2α protein in adipose tissue. PBA tended to decrease circulating fetuin-A and significantly increased circulating fibroblast growth factor 21 (FGF21) without affecting markers of activation of hepatic protein kinase C-δ or p38 mitogen-activated protein kinase that we have previously involved in hepatic insulin resistance in this model. In conclusion: (i) PBA prevented hepatic insulin resistance caused by prolonged plasma FFA elevation without affecting hepatic ER stress markers; (ii) the PBA effect is likely due to increased FGF21 and/or decreased fetuin-A, which directly signal to upregulate Akt activation.

[1]  G. Sumara,et al.  Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review , 2020, Lipids in Health and Disease.

[2]  F. Gómez-Pérez,et al.  Fibroblast growth factor 21 and its novel association with oxidative stress , 2016, Redox biology.

[3]  E. Tsiani,et al.  Rosemary extract reduces Akt/mTOR/p70S6K activation and inhibits proliferation and survival of A549 human lung cancer cells. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  R. Gimeno,et al.  FGF21 Improves the Adipocyte Dysfunction Related to Seipin Deficiency , 2016, Diabetes.

[5]  E. Tsiani,et al.  Effect of a p38 MAPK inhibitor on FFA-induced hepatic insulin resistance in vivo , 2016, Nutrition & Diabetes.

[6]  M. Bartoszewicz,et al.  Phenylbutyrate—a pan-HDAC inhibitor—suppresses proliferation of glioblastoma LN-229 cell line , 2015, Tumor Biology.

[7]  Myung-Shik Lee,et al.  FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs. , 2015, The Journal of endocrinology.

[8]  A. Giacca,et al.  Effect of N-acetyl-l-cysteine on insulin resistance caused by prolonged free fatty acid elevation. , 2015, The Journal of endocrinology.

[9]  S. Kliewer,et al.  Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding , 2014, Diabetes.

[10]  Dongmei Li,et al.  Fibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) Adipocytes , 2014, PloS one.

[11]  R. Proia,et al.  Adipocyte Lipolysis-stimulated Interleukin-6 Production Requires Sphingosine Kinase 1 Activity* , 2014, The Journal of Biological Chemistry.

[12]  I. G. Fantus,et al.  FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress. , 2014, American journal of physiology. Endocrinology and metabolism.

[13]  E. Seto,et al.  Erasers of histone acetylation: the histone deacetylase enzymes. , 2014, Cold Spring Harbor perspectives in biology.

[14]  Xiaokun Li,et al.  Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation , 2013, PloS one.

[15]  S. Mukhopadhyay,et al.  Adipocyte Fetuin-A Contributes to Macrophage Migration into Adipose Tissue and Polarization of Macrophages* , 2013, The Journal of Biological Chemistry.

[16]  G. Shulman,et al.  Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. , 2013, Endocrinology.

[17]  I. G. Fantus,et al.  Duration of rise in free fatty acids determines salicylate's effect on hepatic insulin sensitivity , 2013, The Journal of endocrinology.

[18]  S. Mukhopadhyay,et al.  Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance , 2012, Nature Medicine.

[19]  H. Ou,et al.  Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance. , 2012, Endocrinology.

[20]  Nigel Turner,et al.  Differing Endoplasmic Reticulum Stress Response to Excess Lipogenesis versus Lipid Oversupply in Relation to Hepatic Steatosis and Insulin Resistance , 2012, PloS one.

[21]  S. Kliewer,et al.  Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones , 2012, Cell.

[22]  W. Breitwieser,et al.  The roles of ATF2 (activating transcription factor 2) in tumorigenesis. , 2012, Biochemical Society transactions.

[23]  Y. Kido,et al.  Endoplasmic Reticulum Stress Inhibits STAT3-Dependent Suppression of Hepatic Gluconeogenesis via Dephosphorylation and Deacetylation , 2011, Diabetes.

[24]  G. Shulman,et al.  Influence of the Hepatic Eukaryotic Initiation Factor 2α (eIF2α) Endoplasmic Reticulum (ER) Stress Response Pathway on Insulin-mediated ER Stress and Hepatic and Peripheral Glucose Metabolism , 2011, The Journal of Biological Chemistry.

[25]  G. Lewis,et al.  Sodium Phenylbutyrate, a Drug With Known Capacity to Reduce Endoplasmic Reticulum Stress, Partially Alleviates Lipid-Induced Insulin Resistance and β-Cell Dysfunction in Humans , 2011, Diabetes.

[26]  A. Bookout,et al.  LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice. , 2011, The Journal of clinical investigation.

[27]  B. S. Mohammed,et al.  Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women , 2010, Diabetes.

[28]  M. Pagliassotti,et al.  Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death. , 2010, American journal of physiology. Endocrinology and metabolism.

[29]  A. Volchuk,et al.  GRP78, but Not Protein-disulfide Isomerase, Partially Reverses Hyperglycemia-induced Inhibition of Insulin Synthesis and Secretion in Pancreatic β-Cells* , 2009, Journal of Biological Chemistry.

[30]  A. Mora,et al.  A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.

[31]  Randal J. Kaufman,et al.  From endoplasmic-reticulum stress to the inflammatory response , 2008, Nature.

[32]  H. Ginsberg,et al.  Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. , 2008, The Journal of clinical investigation.

[33]  A. Giacca,et al.  Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo. , 2007, The Journal of endocrinology.

[34]  E. Yilmaz,et al.  Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes , 2006, Science.

[35]  M. Pagliassotti,et al.  Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. , 2006, Endocrinology.

[36]  S. Theocharis,et al.  Histone deacetylase inhibitors: a novel target of anticancer therapy (review). , 2006, Oncology reports.

[37]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[38]  C. Kahn,et al.  Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms , 2004, Molecular and Cellular Biology.

[39]  A. Aljada,et al.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.

[40]  G. Lewis,et al.  Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. , 2002, Endocrine reviews.

[41]  Z. Ronai,et al.  Stability of the ATF2 Transcription Factor Is Regulated by Phosphorylation and Dephosphorylation* , 2000, The Journal of Biological Chemistry.

[42]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[43]  G. Grunberger,et al.  Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. , 1993, Molecular endocrinology.

[44]  A. Chamson-Reig,et al.  Susceptibility to fatty acid-induced β-cell dysfunction is enhanced in prediabetic diabetes-prone biobreeding rats: a potential link between β-cell lipotoxicity and islet inflammation. , 2013, Endocrinology.